Bay Area Biopharma Company Uses ALS to Tackle Sickle Cell Disease
![](https://biosciences.lbl.gov/wp-content/uploads/2017/12/GBT_Figure1.png)
The protein crystallography capabilities at the Advanced Light Source’s (ALS’s) Beamline 8.3.1 have been critical to Global Blood Therapeutics’ (GBT’s) ongoing effort to formulate a better treatment for sickle cell disease (SCD).
More »